Skip to main content
Midas Edge

INTEGRATED BIOPHARMA INC

For the period ended Sep 30, 2024. Filed Nov 13, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 13, 2024

INBPStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 6. EXHIBITS

(a) Exhibits

Exhibit

Number

31.1Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by Co-Chief Executive Officers.
31.2Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by Chief Financial Officer.
32.1Certification of periodic financial report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 by Co-Chief Executive Officers.
32.2Certification of periodic financial report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 by Chief Financial Officer.
101.INS***Inline XBRL InstanceFurnished herewith
101.SCH***Inline XBRL Taxonomy Extension SchemaFurnished herewith
101.CAL***Inline XBRL Taxonomy Extension CalculationFurnished herewith
101.DEF***Inline XBRL Taxonomy Extension DefinitionFurnished herewith
101.LAB***Inline XBRL Taxonomy Extension LabelsFurnished herewith
101.PRE***Inline XBRL Taxonomy Extension PresentationFurnished herewith
104Cover Page Interactive Date File (formatted as Inline XBRL and contained in Exhibit 101)

-24-

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

INTEGRATED BIOPHARMA, INC.

Date: November13, 2024By: /s/ Christina Kay
Christina Kay,
Co-Chief Executive Officer
Date: November13, 2024By: /s/ Riva Sheppard
Riva Sheppard,
Co-Chief Executive Officer
Date: November13, 2024By: /s/ Dina L. Masi
Dina L. Masi,
Chief Financial Officer & Senior Vice President

-25-

-26-

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.